Dysfunctional voltage-gated K+ channels in pulmonary artery smooth muscle cells of patients with primary pulmonary hypertension

Circulation

Volumn 98, Issue 14, 1998, Pages 1400-1406

  Yuan, Jason Xiao Jian ^a   Aldinger, Ann M ^a   Juhaszova, Magdalena ^a   Wang, Jian ^a   Conte Jr , John V ^a   Gaine, Sean P ^a   Orens, Jonathan B ^a   Rubin, Lewis J ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Electrophysiology; Potassium; Pulmonary heart disease

Indexed keywords

POTASSIUM CHANNEL;

ARTERY CONSTRICTION; ARTICLE; CALCIUM CELL LEVEL; CELL MEMBRANE DEPOLARIZATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; LUNG ARTERY; MALE; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SMOOTH MUSCLE FIBER;

EID: 0032491187     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.98.14.1400     Document Type: Article

References (29)

1. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336: 111-117.
2. Palevsky HI, Schloo BL, Pietra GG, Weber KT, Janicki JS, Fishman AP. Primary pulmonary hypertension, vascular structure, morphometry, and responsiveness to vasodilator agents. Circulation. 1989;80:1207-1221.
3. Davies PF, Tripathi S. Mechanical stress mechanisms and the cell. Circ Res. 1993;72:239-245.
4. Dinh-Xuan AT, Higenbottam TW, Clelland CA, Pepke-Zaba J, Cremona G, Butt AY, Large SR, Wells FC, Wallwork J. Impairment of endothelium-dependent pulmonary-artery relaxation in chronic obstructive lung disease. N Engl J Med. 1991;324:1539-1547.
5. Giaid A, Yanagisawa M, Langleben D, Michel RP, Levy R, Shennib H, Kimura S, Masaki T, Duguid WP, Stewart DJ. Expression of endothelin-1 in the lungs of patients with pulmonary hypertension. N Engl J Med. 1993;328:1732-1739.
6. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214-221.
7. Christman BW, McPherson CD, Newman JH, King GA, Bernard GR, Groves BM, Loyd JE. An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992;327:70-75.
8. Wood P. Pulmonary hypertension with special reference to the vasoconstrictive factor. Br Heart J. 1958;20:557-570.
9. Wagenvoort CA, Wagenvoort N. Primary pulmonary hypertension: a pathologic study of the lung vessels in 156 clinically diagnosed cases. Circulation. 1970;42:1163-1184.
10. Kolpakov V, Rekhtar MD, Gordon D, Wang WH, Kulik TJ. Effect of mechanical forces on growth and matrix protein synthesis in the in vitro pulmonary artery: analysis of the role of individual cell types. Circ Res. 1995;77:823-831.
11. Pietra GG. The pathology of primary pulmonary hypertension. In: Rubin LJ, Rich S, eds. Primary Pulmonary Hypertension. New York, NY: Marcel Dekker; 1997:19-61.
12. Brink C, Cerrina C, Labat C, Verley J, Benveniste J. The effects of contractile agonists on isolated pulmonary arterial and venous muscle preparations derived from patients with primary pulmonary hypertension. Am Rev Respir Dis. 1988;137(pt 2):A106. Abstract.
13. Rich S, Kaufmann E, Levy PS. The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension. N Engl J Med. 1992;327:76-81.
14. Nelson MT, Patlak JB, Worley JF, Standen NB. Calcium channels, potassium channels, and voltage-dependence of arterial smooth muscle tone. Am J Physiol. 1990;259:C3-C18.
15. Berridge MJ. Calcium signaling and cell proliferation. Bioessays. 1995; 17:491-500.
16. Clapham DE. Calcium signaling. Cell. 1995;80:259-268.
17. i in pulmonary arterial myocytes. Circ Res. 1995;77:370-378.
18. Fleischmann BK, Murray RK, Kotlikoff MI. Voltage window for sustained elevation of cytosolic calcium in smooth muscle cells. Proc Natl Acad Sci U S A. 1994;91:11914-11918.
19. Peng W, Karwande SV, Hoidal JR, Farrukh IS. Potassium currents in cultured human pulmonary arterial smooth muscle cells. J Appl Physiol. 1996;80:1187-1196.
20. Nelson MT, Quayle JM. Physiological roles and properties of potassium channels in arterial smooth muscle. Am J Physiol. 1995;268:C799-C822.
21. Weir EK, Reeve HL, Huang JMC, Michelakis E, Nelson DP, Archer SL. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation. 1996;94:2216-2220.
22. Abenhaim L, Moride Y, Brenot F, Rich S, Benichou J, Kurz X, Higenbottam T, Oakley C, Wouters E, Aubier M, Simonneau G, Begaud B. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335:509-516.
23. + channel gene transcription and expression in clonal pituitary cells. Neuron. 1993;11:359-369.
24. + channel gene transcription in primary pulmonary hypertension. Lancet. 1998;351:726-727.
25. Allbritton NL, Oancea E, Kuhn MA, Meyer T. Source of nuclear calcium signals. Proc Natl Acad Sci U S A. 1994;91:12458-12462.
26. + channels. Proc Natl Acad Sci U S A. 1996;93:10489-10494.
27. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Circ Res. 1996;78:415-423.
28. + channels. J Physiol. 1995;483:115P-116P.
29. + current in rat intrapulmonary arterial myocytes by endothelin-1. Am J Physiol. 1998;274:L842-L853.